home / stock / zyme / zyme quote
Last: | $6.43 |
---|---|
Change Percent: | 0.47% |
Open: | $6.39 |
Close: | $6.43 |
High: | $6.6 |
Low: | $6.23 |
Volume: | 1,007,698 |
Last Trade Date Time: | 12/15/2022 03:41:52 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.43 | $6.39 | $6.43 | $6.6 | $6.23 | 1,007,698 | 12-15-2022 |
$6.42 | $6.16 | $6.42 | $6.665 | $5.98 | 1,320,850 | 12-14-2022 |
$6.18 | $6.11 | $6.18 | $6.43 | $5.7601 | 735,473 | 12-13-2022 |
$6 | $6.58 | $6 | $6.68 | $5.95 | 1,350,646 | 12-12-2022 |
$6.71 | $7.24 | $6.71 | $8.22 | $6.56 | 1,331,614 | 12-09-2022 |
$7.08 | $7.48 | $7.08 | $7.63 | $7.045 | 603,505 | 12-08-2022 |
$7.4 | $7.12 | $7.4 | $7.55 | $6.6 | 1,463,499 | 12-07-2022 |
$7.03 | $7.64 | $7.03 | $8.07 | $6.94 | 2,240,498 | 12-06-2022 |
$7.62 | $7.56 | $7.62 | $7.73 | $7.32 | 892,131 | 12-05-2022 |
$7.58 | $7.73 | $7.58 | $7.78 | $7.17 | 1,059,851 | 12-02-2022 |
$7.73 | $7.77 | $7.73 | $8.0225 | $7.61 | 216,034 | 12-01-2022 |
$7.72 | $7.77 | $7.72 | $7.95 | $7.51 | 377,118 | 11-30-2022 |
$7.71 | $7.75 | $7.71 | $7.94 | $7.6 | 340,461 | 11-29-2022 |
$7.83 | $7.91 | $7.83 | $8.15 | $7.77 | 501,872 | 11-28-2022 |
$7.84 | $8.07 | $7.84 | $8.13 | $7.66 | 350,079 | 11-25-2022 |
$8.04 | $7.8 | $8.04 | $8.15 | $7.6894 | 551,520 | 11-24-2022 |
$8.04 | $7.8 | $8.04 | $8.15 | $7.6894 | 551,520 | 11-23-2022 |
$7.76 | $8.03 | $7.76 | $8.03 | $7.41 | 632,987 | 11-22-2022 |
$7.95 | $7.84 | $7.95 | $7.99 | $7.575 | 807,924 | 11-21-2022 |
$7.76 | $8.01 | $7.76 | $8.01 | $7.58 | 289,143 | 11-18-2022 |
News, Short Squeeze, Breakout and More Instantly...
2024-04-15 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing ...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that manag...